AGIC Capital acquires majority stake in aseptic solutions provider ATEC

Erik Yankulin, Managing Director at AGIC Capital

AGIC Capital (AGIC), a growth-oriented private equity firm with $2.2 billion of assets under management, announced that it had acquired a majority stake in ATEC Pharmatechnik GmbH. The sellers, ATEC’s founder and Chief Executive Officer, Hans-Werner Mumm, and family-backed Mittelstand investor HANNOVER Finanz Group, will remain invested in the Company, and Hans-Werner Mumm will continue to act as its Chief Executive Officer.

What does the acquisition mean for ATEC?

ATEC is a manufacturer of aseptic processing solutions, used in pharmaceutical manufacturing and bioprocessing applications, with a customer base that includes the top 10 pharmaceutical firms. ATEC’s products include stopper and cap processing systems used for aseptic filling, RTP transfer ports and ancillary single-use transfer bag solutions. These mission-critical tech enable ATEC’s customers to establish safe and reliable manufacturing process environments.

This is anticipated to be the first of several acquisitions as AGIC builds a specialty process technologies platform focused on pharmaceutical and biopharmaceutical end markets.

Hans-Werner Mumm, CEO of ATEC commented, “We are excited to partner with AGIC, a firm that shares our passion for providing our customers with safer aseptic transfer technologies, which are critical to the future of medicine. We look forward to expanding our critical role in pharmaceutical manufacturing and bioprocessing as we invest in our next phase of growth.”

What does ATEC bring to AGIC’s portfolio?

Erik Yankulin, MD at AGIC, said, “ATEC supports the production of life-saving therapies by providing top aseptic transfer tech to pharmaceutical and biopharmaceutical firms.”

“Specifically, the firm’s products provide industry-leading solutions for handling sterile drug products across the most demanding pharmaceutical manufacturing applications in the areas of diabetes, oncology and others. We are excited to support ATEC through investments into new product development, go-to-market capabilities, and add-on acquisitions,” Yankulin said.

Frank Löffler, Partner at HANNOVER Finanz said, “We have worked closely with Hans-Werner and ATEC’s management team since 2018 to grow the business, its customer base and innovative product offering. We believe in the company’s potential and wish AGIC as the future majority shareholder the best of success in driving the next chapter of ATEC’s growth.”

ATEC and HANNOVER Finanz were advised by Macquarie Capital with Latham & Watkins LLP advising the sellers, while AGIC was supported by White & Case LLP in the acquisition.